Vice President
Clinical Pharmacology Modeling & Simulation, Infectious Diseases and Vaccines, Precision Medicine, GlaxoSmithKline
Collegeville, Pennsylvania
Mindy Magee, PharmD, Vice President, Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline, Collegeville, PA
Mindy Magee is Vice President of Infectious Diseases and Vaccines of Clinical Pharmacology Modeling and Simulation at GlaxoSmithKline, Collegeville, PA. Mindy received a Bachelor of Science and a Doctor of Pharmacy degrees from the University of New York at Buffalo followed by a post-doctoral Fellowship focused on PK/PD modeling of immune cells trafficking in humans. During her 20+ years tenure at GSK, her experience spans across Research and Development of small and large molecules in multiple therapeutic areas including metabolic and cardiovascular diseases, women’s health, and ophthalmology. In her current role, Mindy is accountable for the clinical pharmacology and pharmacometrics including QSP strategy and delivery of global R&D in hepatology, infectious diseases, and vaccines. Mindy’s areas of scientific and research interests include mechanistic understanding of drug and disease, model informed drug and vaccine development enabling better and faster decision making in the treatment and prevention of diseases throughout the continuum of global R&D.
Disclosure information not submitted.
Keynote: Model Informed Vaccine Development (MIVD) – Challenges and Opportunities
Wednesday, October 23, 2024
1:30 PM – 2:30 PM MT